- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
You can request one free hour of our analysts time when you purchase this market report. Details are
provided within the report.
MIR Announces the Publication of its Research Report Global Cystic Fibrosis Therapeutics Market 2018-
2022
MIR recognizes the following companies as the key players in the global cystic fibrosis therapeutics
market: AbbVie, Gilead, F. Hoffmann-La Roche, and Vertex Pharmaceuticals.
Get full access to this report at https://www.marketinsightsreports.com/reports/0227267986/global-
cystic-fibrosis-therapeutics-market-2018-2022
Commenting on the report, an analyst from MIR's team said: One trend in the market is strategic
collaborations. M&A are usually intended to enhance a company's product portfolio and increase the
acquiring company's market penetration. Established pharmaceutical companies acquire late-stage
products from small companies, where the efficacy of products has already been demonstrated, thereby
cutting down on initial R&D expenditure.
According to the report, one driver in the market is improved diagnostic technologies. CF is a genetically
inherited disease. Several diagnostic tests are available to detect the disease. Some of the popular
methods of diagnosis are antenatal testing, carrier testing, and other tests such as genetic tests and
sweat tests. Growing investment in and awareness about genetic diseases are expected to lead to
improved diagnostic technologies, which will drive the growth of the market.
Further, the report states that one challenge in the market is drug discontinuation. Discontinuation of
drugs from the development stage or from the market after their launch is a major challenge for
investors and drug manufacturers. The discontinuation of drugs from the late-stage development or
after approval due to reasons such as safety concerns leads to a significant financial loss for investors
because of the high R&D and marketing costs involved in the process of drug development.
The study was conducted using an objective combination of primary and secondary information
including inputs from key participants in the industry. The report contains a comprehensive market and
vendor landscape in addition to a SWOT analysis of the key vendors.
About Us:-
MarketInsightsReports provides syndicated market research reports to industries, organizations or even
individuals with an aim of helping them in their decision making process. These reports include in-depth
market research studies i.e. market share analysis, industry analysis, information on products, countries,
market size, trends, business research details and much more. MarketInsightsReports provides global
and regional market intelligence coverage, a 360-degree market view which includes statistical
forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.